Amgen | AMGN - الدائنين التجاريين

سعر السهم
339.57
التغيير اليومي
-0.61 -0.18%
شهريا
-2.70%
سنويا
17.68%
Q2 التوقعات
337.18




الدائنين التجاريين تغيير تاريخ
AbbVie USD 3.59B 28.65B 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Genmab DKK 6M 2M 2025-09
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 10.46B 1.53B 2026-03
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12